Caballero Ruben 4

4 · Corvex, Inc. · Filed Jun 26, 2026

AI-generated summary of this filing

Updated Jun 26, 2026

Corvex (MOVE) Director Ruben Caballero Exercises Options

What Happened

Ruben Caballero, a director of Corvex, exercised stock options on June 25, 2026 to acquire 29,197 shares of Corvex common stock at an exercise price of $0.92 per share, for a reported cash outlay of $26,861. The Form 4 also reports a related entry showing a 29,197-share derivative disposition with $0.00 proceeds (reported as a separate derivative conversion/disposition).

Key Details

Transaction date: 2026-06-25 (Form 4 filed 2026-06-26 — timely within SEC reporting window).
Exercise: 29,197 shares at $0.92 = $26,861 (reported as Code M: option exercise/conversion).
Related derivative entry: 29,197 shares reported as disposed at $0.00 (listed separately in the filing).
Shares owned after transaction: not specified in the information provided in this summary.
Footnotes: F1 notes a 2026 stock dividend (1.358-for-1) that adjusted share counts and prices; F2 notes the option award was originally granted contingent on a Plan Amendment and became exercisable after shareholder approval (Dec 16, 2025).

Context

This was an exercise of options, not an open-market sale—no market sale of the acquired shares is recorded in the filing. For retail investors, option exercises can be routine (e.g., to vest/hold or for tax planning); they are not necessarily a directional signal like a purchase or sale. The filing reflects administrative adjustments tied to a recent stock dividend and the prior plan amendment that authorized the award.

Form 4

Period: 2026-06-25

Director

Transactions

Exercise/Conversion
Common Stock
[F1]
2026-06-25$0.92/sh+29,197$26,861→ 38,017 total
Exercise/Conversion
Stock Options (Right to Buy)
[F2]
2026-06-25−29,197→ 0 total
Exercise: $0.92Exp: 2026-06-30→ Common Stock (29,197 underlying)

Footnotes (2)

[F1]As a result of the Company's stock dividend, each share of Common Stock issued and outstanding at the close of business on March 30, 2026 was automatically converted into 1.358 shares of Common Stock and was distributed on approximately April 6, 2026. The amounts reported on this Form 4 reflect the impacts of such stock dividend.
[F2]This option award was granted contingent upon shareholder approval of an amendment to the Omnibus Incentive Plan that increases the number of shares of Common Stock authorized for issuance under the Plan (the "Plan Amendment"). The option became exerciseable upon shareholder approval of the Plan Amendment on December 16, 2025. The number of subject shares and the exercise price of such option award has been adjusted by the stock dividend.

Signature

/s/ Ruben Caballero by Mark R. Busch, attorney-in-fact|2026-06-26

1 file